Accounting for Product Impact in the Pharmaceuticals Industry

22 Pages Posted: 2 Jul 2021

See all articles by Amanda Rischbieth

Amanda Rischbieth

Harvard TH Chan School of Public Health; University of Adelaide

George Serafeim

Harvard Business School

Katie Trinh

Brown University, Department of Economics, Students

Date Written: June 30, 2021

Abstract

We apply the product impact measurement framework of the Impact-Weighted Accounts Initiative (IWAI) in two competitor companies within the pharmaceuticals industry. We design a monetization methodology that allows us to calculate monetary impact estimates of accessible product provision and efficacy, among other factors. Our results indicate substantial differences in the impact that competitors have through their products. These differences demonstrate how impact reflects corporate strategy and informs decision-making on industry-specific areas.

Suggested Citation

Rischbieth, Amanda and Serafeim, George and Trinh, Katie, Accounting for Product Impact in the Pharmaceuticals Industry (June 30, 2021). Harvard Business School Accounting & Management Unit Working Paper No. 21-139, Available at SSRN: https://ssrn.com/abstract=3877517 or http://dx.doi.org/10.2139/ssrn.3877517

Amanda Rischbieth

Harvard TH Chan School of Public Health ( email )

Boston, MA 02115
United States

University of Adelaide ( email )

No 233 North Terrace, School of Commerce
Adelaide, South Australia 5005
Australia

George Serafeim (Contact Author)

Harvard Business School ( email )

Boston, MA 02163
United States

HOME PAGE: http://www.hbs.edu/faculty/Pages/profile.aspx?facId=15705

Katie Trinh

Brown University, Department of Economics, Students ( email )

Providence, RI
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
22
Abstract Views
199
PlumX Metrics